FIELD: medicine, gynecology.
SUBSTANCE: one should introduce for a patient twice monthly 50 mln fetal stem mesenchymal human cells intravenously and 6x109 fetal stem neutral cells intramuscularly. The innovation enables to obtain stable curative effect in short terms at minimum of contraindications at no side phenomena.
EFFECT: higher efficiency of therapy.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING BLADDER HYPOTENSION WITH USING ADIPOSE MESENCHYMAL STEM CELLS | 2019 |
|
RU2712029C1 |
| METHOD FOR TREATING STRESS-INDUCED URINARY INCONTINENCE | 2005 |
|
RU2286790C1 |
| METHOD FOR PRODUCTION OF CELL CULTURE FOR TREATMENT OF VASCULAR DEMYELINATING DISEASES OF NERVOUS SYSTEM AND CELL CULTURE PRODUCED BY THIS METHOD (VERSIONS) | 2007 |
|
RU2347579C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING DILATION CARDIOMYOPATHY | 2004 |
|
RU2268062C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF DIABETES MELLITUS OF TYPE I AND II | 2004 |
|
RU2265443C1 |
| BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC LOWER EXTREMITY ISCHEMIA CASES | 2005 |
|
RU2286159C1 |
| VAGINAL SUPPOSITORIES FOR TREATING IMPERATIVE INCONTINENCE OF URINE | 2003 |
|
RU2241442C1 |
| METHOD FOR TREATING CHILDREN FOR NEUROGENOUS URINARY BLADDER HYPERREFLEXIA | 2003 |
|
RU2250784C1 |
| METHOD OF TREATING CONSEQUENCES OF HERPETIC MENINGOENCEPHALITIS WITH USE OF AUTOLOGOUS MESENCHYMAL STEM CELLS | 2011 |
|
RU2470649C1 |
| BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
